Nicholson Donald William 4

What Happened

• Donald William Nicholson, a director of Disc Medicine, was granted a derivative award covering 6,212 shares on 2026-06-18. The Form 4 reports an acquisition (code A) at $0.00 per share (reported value $0). This was an equity award/option grant — not a purchase or sale of stock.

Key Details

• Transaction date: 2026-06-18; Filing date (Form 4): 2026-06-23 (filed 5 days after the grant; appears to be after the usual two-business-day reporting window).
• Amount: 6,212 shares underlying a derivative award; price reported $0.00.
• Shares owned after transaction: Not specified in the provided data.
• Footnote: The shares underlying this option vest upon the earlier of (i) the Company’s 2027 annual meeting of stockholders or (ii) the one‑year anniversary of the grant date, contingent on the Reporting Person’s continued service on the vesting date.

Context

• This was a time‑based equity award (derivative grant) that vests in the future; no shares were sold or exercised at grant. Such awards are commonly used for retention or compensation and do not by themselves indicate an immediate change in insider sentiment.